Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Andrew F Donnell

7PUBLICATIONS
32CO-AUTHORS
Regenerative medicine (incl. stem cells)Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMolecular targetsOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Nov 24, 2025
Discovery and Characterization of Novel BLIMP-1 Heterobifunctional Ligand-Directed Degraders.

Bryan J Simmons, Lynda Groocock, Jesus Moreno

|Sep 25, 2025
Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation Pathway.

James J Mignone, Elizabeth A Jurica, Deepa Rajasekaran

|Feb 14, 2024
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology.

Liqi He, Meng Yao Zhang, Matthew Cox

|Feb 14, 2024
Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology.

Yam B Poudel, Liqi He, Matthew Cox

|Aug 03, 2022
Ni/Photoredox-Catalyzed C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Cross-Coupling of Alkyl Pinacolboronates and (Hetero)Aryl Bromides.

Anthony N Cauley, Antonio Ramirez, Chandan L Barhate

|Oct 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor.

Yong Zhang, Karen E Parrish, David R Tortolani

Pageof 2

Frequent Collaborators

3 joint publications

Cullen L Cavallaro

3 joint publications

Yong Zhang

2 joint publications

Martins S Oderinde

2 joint publications

Prasanna Sivaprakasam

2 joint publications

Ashvinikumar V Gavai

2 joint publications

Murugaiah A M Subbaiah

2 joint publications

Yam B Poudel

1 joint publications

Jennifer R Riggs

1 joint publications

Xiaoping Hou

1 joint publications

Louis J Lombardo

Frequent Collaborators

3 joint publications

Cullen L Cavallaro

3 joint publications

Yong Zhang

2 joint publications

Martins S Oderinde

2 joint publications

Prasanna Sivaprakasam

Top Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

10.9K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on : Nov 22, 2024

621
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.5K
See more related videos

Top Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

10.9K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on : Nov 22, 2024

621
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.5K
See more related videos